Guerbet SA

Informe acción ENXTPA:GBT

Capitalización de mercado: €331.6m

Guerbet Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Los beneficios de Guerbet han disminuido a una tasa media anual de -31.2%, mientras que en la industria Medical Equipment los beneficios crecieron en un 14.5% anualmente. Los ingresos han ido creciendo a una tasa media de 0.4% al año. La rentabilidad financiera de Guerbet es de 8%, y sus márgenes netos son de 3.9%.

Información clave

-31.2%

Tasa de crecimiento de los beneficios

-31.2%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment 21.6%
Tasa de crecimiento de los ingresos0.4%
Rentabilidad financiera8.0%
Margen neto3.9%
Próxima actualización de resultados27 Mar 2025

Actualizaciones de resultados anteriores recientes

Recent updates

Guerbet SA (EPA:GBT) Might Not Be As Mispriced As It Looks After Plunging 29%

Nov 16
Guerbet SA (EPA:GBT) Might Not Be As Mispriced As It Looks After Plunging 29%

Is Guerbet (EPA:GBT) Using Too Much Debt?

Apr 27
Is Guerbet (EPA:GBT) Using Too Much Debt?

Further Upside For Guerbet SA (EPA:GBT) Shares Could Introduce Price Risks After 48% Bounce

Feb 29
Further Upside For Guerbet SA (EPA:GBT) Shares Could Introduce Price Risks After 48% Bounce

Returns On Capital At Guerbet (EPA:GBT) Paint A Concerning Picture

Feb 11
Returns On Capital At Guerbet (EPA:GBT) Paint A Concerning Picture

Guerbet SA (EPA:GBT) Screens Well But There Might Be A Catch

Jan 15
Guerbet SA (EPA:GBT) Screens Well But There Might Be A Catch

The Returns On Capital At Guerbet (EPA:GBT) Don't Inspire Confidence

Jul 22
The Returns On Capital At Guerbet (EPA:GBT) Don't Inspire Confidence

Guerbet SA's (EPA:GBT) Intrinsic Value Is Potentially 92% Above Its Share Price

Jul 27
Guerbet SA's (EPA:GBT) Intrinsic Value Is Potentially 92% Above Its Share Price

Analysts Have Been Trimming Their Guerbet SA (EPA:GBT) Price Target After Its Latest Report

Mar 28
Analysts Have Been Trimming Their Guerbet SA (EPA:GBT) Price Target After Its Latest Report

Is Guerbet (EPA:GBT) A Risky Investment?

Oct 25
Is Guerbet (EPA:GBT) A Risky Investment?

The Returns On Capital At Guerbet (EPA:GBT) Don't Inspire Confidence

Sep 23
The Returns On Capital At Guerbet (EPA:GBT) Don't Inspire Confidence

Is Now The Time To Look At Buying Guerbet SA (EPA:GBT)?

May 27
Is Now The Time To Look At Buying Guerbet SA (EPA:GBT)?

We Think Guerbet (EPA:GBT) Is Taking Some Risk With Its Debt

May 04
We Think Guerbet (EPA:GBT) Is Taking Some Risk With Its Debt

Is Guerbet SA (EPA:GBT) A Good Fit For Your Dividend Portfolio?

Apr 05
Is Guerbet SA (EPA:GBT) A Good Fit For Your Dividend Portfolio?

Guerbet SA's (EPA:GBT) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Mar 19
Guerbet SA's (EPA:GBT) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

What Type Of Shareholders Make Up Guerbet SA's (EPA:GBT) Share Registry?

Mar 01
What Type Of Shareholders Make Up Guerbet SA's (EPA:GBT) Share Registry?

When Should You Buy Guerbet SA (EPA:GBT)?

Feb 10
When Should You Buy Guerbet SA (EPA:GBT)?

How Much Did Guerbet's(EPA:GBT) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 28
How Much Did Guerbet's(EPA:GBT) Shareholders Earn From Share Price Movements Over The Last Three Years?

Guerbet SA (EPA:GBT) Shares Could Be 25% Above Their Intrinsic Value Estimate

Jan 13
Guerbet SA (EPA:GBT) Shares Could Be 25% Above Their Intrinsic Value Estimate

Would Guerbet SA (EPA:GBT) Be Valuable To Income Investors?

Dec 23
Would Guerbet SA (EPA:GBT) Be Valuable To Income Investors?

We Think Guerbet's (EPA:GBT) Statutory Profit Might Understate Its Earnings Potential

Dec 11
We Think Guerbet's (EPA:GBT) Statutory Profit Might Understate Its Earnings Potential

Do Its Financials Have Any Role To Play In Driving Guerbet SA's (EPA:GBT) Stock Up Recently?

Nov 27
Do Its Financials Have Any Role To Play In Driving Guerbet SA's (EPA:GBT) Stock Up Recently?

Desglose de ingresos y gastos

Cómo gana y gasta dinero Guerbet. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

ENXTPA:GBT Ingresos, gastos y beneficios (EUR Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Jun 24841334940
31 Mar 24818284820
31 Dec 23796244710
30 Sep 23785-94700
30 Jun 23775-424690
31 Mar 23772-424590
31 Dec 22769-414500
30 Sep 22757-144390
30 Jun 22746134270
31 Mar 22741234180
31 Dec 21736334080
30 Sep 21724334050
30 Jun 21712334020
31 Mar 21715264110
31 Dec 20717184200
30 Sep 20751224290
30 Jun 20785264380
31 Mar 20802324520
31 Dec 19819374660
30 Sep 19813404680
30 Jun 19807434700
31 Mar 19801454630
31 Dec 18795474570
30 Sep 18793464560
30 Jun 18790464550
31 Mar 18800464530
31 Dec 17809464510
30 Sep 17807434480
30 Jun 17805404440
31 Mar 17791344380
31 Dec 16776294310
30 Sep 16709303980
30 Jun 16642313660
31 Mar 16566353190
31 Dec 15490392720
30 Sep 15462372560
30 Jun 15435352410
31 Mar 15422302350
31 Dec 14410262280
30 Sep 14405242260
30 Jun 14400232240
31 Mar 14395222230
31 Dec 13391202220

Ingresos de calidad: GBT tiene ganancias de alta calidad.

Margen de beneficios creciente: GBT pasó a ser rentable.


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de GBT han disminuido en un 31.2% al año en los últimos 5 años.

Acelerando crecimiento: GBT ha pasado a ser rentable en el último año, lo que dificulta la comparación de la tasa de crecimiento de los beneficios con su promedio de 5 años.

Beneficios vs. Industria: GBT ha pasado a ser rentable en el último año, lo que es difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Medical Equipment (12.7%).


Rentabilidad financiera

Alta ROE: La rentabilidad financiera de GBT (8%) se considera baja.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado